Equities Analysts Offer Predictions for Humana Q1 Earnings

Humana Inc. (NYSE:HUM) – Analysts at Zacks Research upped their Q1 2027 EPS estimates for shares of Humana in a report released on Wednesday, August 12th. Zacks Research analyst Team now expects that the insurance provider will earn $9.04 per share for the quarter, up from their previous estimate of $8.70. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Humana’s current full-year earnings is $9.09 per share.

Several other equities analysts also recently weighed in on the company. Cantor Fitzgerald increased their price target on Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a report on Tuesday, July 7th. Mizuho lifted their price objective on shares of Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Wolfe Research upgraded shares of Humana from a “peer perform” rating to an “outperform” rating in a research report on Thursday, July 30th. Morgan Stanley upgraded shares of Humana from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Finally, Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a research note on Thursday, July 30th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $395.22.

Humana Price Performance

NYSE:HUM opened at $388.86 on Thursday. The firm has a market capitalization of $46.69 billion, a price-to-earnings ratio of 36.79, a PEG ratio of 2.13 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The business has a 50 day simple moving average of $380.56 and a 200-day simple moving average of $274.05. Humana has a 1 year low of $163.11 and a 1 year high of $428.88.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same quarter last year, the business posted $6.27 earnings per share. The firm’s revenue was up 26.2% on a year-over-year basis.

Institutional Investors Weigh In On Humana

Several hedge funds and other institutional investors have recently modified their holdings of the business. Montag A & Associates Inc. grew its position in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. Johnson Financial Group Inc. bought a new stake in shares of Humana during the second quarter worth $26,000. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the fourth quarter worth $27,000. Trust Co. of Vermont purchased a new stake in shares of Humana during the second quarter valued at $28,000. Finally, Reflection Asset Management purchased a new stake in shares of Humana during the fourth quarter valued at $29,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.